Douglas E Williams Codiak Bio Sciences, Inc. (CDAK) insider trading activity

Douglas E Williams is President & CEO of Codiak BioSciences, Inc.. Currently has a direct ownership of 7,655 shares of CDAK, which is worth approximately $76. The most recent transaction as insider was on Mar 28, 2023, when has been sold 41,667 shares (Common Stock) at a price of $0.18 per share, resulting in proceeds of $7,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.66K

0% 3M change

0% 12M change

Total Value Held $76

DOUGLAS E WILLIAMS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 28 2023	SELL Open market or private sale	$7,500 $0.18 p/Share	41,667 Reduced 84.48%	7,655 Common Stock
Feb 17 2023	SELL Open market or private sale	$4,531 $0.59 p/Share	7,681 Reduced 13.47%	49,322 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	22,969 Added 28.72%	57,003 Common Stock
Jan 20 2023	SELL Open market or private sale	$2,892 $0.57 p/Share	5,075 Reduced 21.83%	18,177 Common Stock
Jan 19 2023	BUY Exercise of conversion of derivative security	-	13,667 Added 37.02%	23,252 Common Stock
Aug 17 2022	SELL Open market or private sale	$15,717 $2.21 p/Share	7,112 Reduced 17.28%	34,034 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	-	22,969 Added 35.82%	41,146 Common Stock
Oct 16 2020	BUY Conversion of derivative security	-	9,585 Added 50.0%	9,585 Common Stock

Also insider at

SANA

Sana Biotechnology, Inc. Healthcare

EVP & President, R&D

OVID

Ovid Therapeutics Inc. Healthcare

Director

ELYM

Eliem Therapeutics, Inc. Healthcare

DEW